$7.30
0.223.10%
Pre-Market: Jan 17, 4:16 PM EDT
Comments
Loading...
Latest news for Sage Therapeutics (NASDAQ:SAGE) Stock
Sage Therapeutics Stock (NASDAQ: SAGE)
Categories: All
Friday, January 17, 2025
Monday, January 13, 2025
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts
- Sage Therapeutics shares are trading higher a...
- Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
- Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
- Why Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday?
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
- Reported Saturday, Sage Therapeutics Confirms...
Thursday, January 02, 2025
Monday, December 16, 2024
Thursday, November 21, 2024
Wednesday, November 20, 2024
- HC Wainwright & Co. Reiterates Neutral on Sag...
- After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
- Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
- Needham Reiterates Hold on Sage Therapeutics
- Sage Therapeutics Announced Topline Results F...
Friday, November 01, 2024
Wednesday, October 30, 2024
- Scotiabank Maintains Sector Outperform on Sag...
- Piper Sandler Reiterates Overweight on Sage T...
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Oppenheimer Maintains Perform on Sage Therape...
- Truist Securities Maintains Hold on Sage Ther...
- Sage Therapeutics shares are trading lower af...
- HC Wainwright & Co. Maintains Neutral on Sage...
- Needham Reiterates Hold on Sage Therapeutics
Tuesday, October 29, 2024
Monday, October 28, 2024
Thursday, October 17, 2024
Thursday, October 10, 2024
Wednesday, October 09, 2024
Tuesday, October 08, 2024
- Needham Reiterates Hold on Sage Therapeutics
- After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Market-Moving News for October 8th
- Sage Therapeutics shares are trading lower af...
- Sage Therapeutics Reports Results From Phase ...